Practice
Featured experience
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
J.F. Lehman closes $2.2 billion Fund VI
We advised J.F. Lehman on the fundraise and related matters
GHK Capital Partners completes $870 million fundraise for its second fund
We advised GHK Capital Partners on the fundraise and related matters for GHK Fund II
Grayscale Bitcoin Trust approved as world’s largest bitcoin ETF
We advised Grayscale in the yearslong effort to secure SEC approval for the NYSE Arca listing
Morgan Stanley $3 billion subordinated notes offering
We advised Morgan Stanley on its SEC-registered global offering
Banco Santander $1.5 billion senior non-preferred notes offering
We advised Banco Santander on its SEC-registered offering of senior non-preferred callable fixed-to-fixed-rate notes
Clarivate $631 million secondary offering
We advised Clarivate on the registered secondary offering of its ordinary shares
Maravai LifeSciences $1 billion secondary offering
The shares are listed on the Nasdaq Global Select Market
MSCI $700 million notes offering
We advised MSCI on its Rule 144A / Regulation S offering of senior notes
Viveo R$1.9 billion IPO
We advised Viveo and the selling shareholders on its IPO and São Paulo Stock Exchange listing
Raízen R$6 billion IPO
We advised Raízen on its IPO and São Paulo Stock Exchange listing
Morgan Stanley C$1 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering of fixed-to-floating-rate notes
Tenaya Therapeutics $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Lightyear Capital acquisition of Wren Sterling
We are advising Lightyear Capital on the acquisition